Mualliflar

  • Убайдуллаева З.И., Усмоналиева Б.В.

##semicolon##

латентный вирусный гепатит B, латентный вирусный гепатит C, доноры крови, анти-HBc, анти-HCV, ДНК HBV, РНК HCV, серологические профили, ПЦР.

##submission.citations##

World Health Organization. (2023). Global hepatitis report 2023. Geneva: WHO.

World Health Organization. (2022). Hepatitis C fact sheet. Geneva: WHO.

Raimondo, G., Locarnini, S., Pollicino, T., Levrero, M., Zoulim, F., & Lok, A. S. (2019). Update of the statements on biology and clinical impact of occult hepatitis B virus infection. Journal of Hepatology, 71(2), 397–408. https://doi.org/10.1016/j.jhep. 2019.03.034

Allain, J. P., & Candotti, D. (2017). Hepatitis B virus in transfusion medicine: Still a problem? Biologicals, 48, 1–10. https: //doi.org/10.1016/j.biologicals.2017.02.00

Fopa, D., Candotti, D., Tagny, C. T., Doux, C., Mbanya, D., & Allain, J. P. (2019). Occult hepatitis B infection among blood donors from a highly endemic area. BMC Infectious Diseases, 19, 313. https://doi.org/10. 1186/s12879-019-3926-9

Stramer, S. L., Dodd, R. Y., & Katz, L. M. (2011). Emerging infectious disease screening in blood donors. Transfusion, 51(7), 1359–1370. https://doi.org/10.1111 /j.1537-2995.2011. 03120.x

Laperche, S., Tiberghien, P., Roche-Longin, C., et al. (2017). Fifteen years of HCV nucleic acid testing in blood donors. Transfusion Clinique et Biologique, 24(3), 201–207. https://doi.org/10.1016/j.tracli.2017. 05.004

Seo, S. I., Kim, H. S., Kim, J. H., et al. (2018). Prevalence and clinical significance of anti-HBc positivity in blood donors. Journal of Viral Hepatitis, 25(3), 292–300. https://doi.org/10.1111/jvh.12821

Minuk, G. Y., Sun, D. F., Uhanova, J., et al. (2020). Occult hepatitis B virus infection in a North American blood donor population. Canadian Journal of Gastroenterology and Hepatology, 2020, 1–7. https:// doi.org/10.1155/2020/8890134.